Article
Genetic variation in cannabinoid receptor 1 (CNR1) is associated with derangements in lipid homeostasis, independent of body mass index.
Pharmacogenomics - 1 Nov 2008
Baye Tes M, Zhang Yi, Smith Edward, Hillard Cecilia J, Gunnell Jennifer, Myklebust Joel, James Roland, Kissebah Ahmed H, Olivier Michael, Wilke Russell A
Abstract excerpt
AIMS: In humans, genetic variation in endocannabinergic signaling has been associated with anthropometric measures of obesity. In randomized trials, pharmacological blockade at the level of the cannabinoid receptor 1 (CNR1) receptor not only facilitates weight reduction, but also improves insulin sensitivity and clinical measures of lipid homeostasis. We therefore tested the hypothesis that genetic variation in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
